Bristol-Myers Squibb to Take Part at the Morgan Stanley Conference

NEW YORK--()--Bristol-Myers Squibb Company (NYSE: BMY) will take part in a fireside chat at the Morgan Stanley Conference on Monday, September 9, 2019, in New York. Giovanni Caforio, M.D., chairman and chief executive officer will answer questions at 4:15 p.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

Contacts

Media: Carrie Fernandez, 609-252-5222, carrie.fernandez@bms.com
Investors: Tim Power, 609-252-7509, timothy.power@bms.com

Release Summary

Bristol-Myers Squibb to Take Part at the Morgan Stanley Conference

Contacts

Media: Carrie Fernandez, 609-252-5222, carrie.fernandez@bms.com
Investors: Tim Power, 609-252-7509, timothy.power@bms.com